about
Ephedrine for myasthenia gravis, neonatal myasthenia and the congenital myasthenic syndromesDonepezil: a clinical review of current and emerging indications.Mary Broadfoot Walker (1888-1974): a historic discovery in myasthenia gravis.Available treatment options for the management of Lambert-Eaton myasthenic syndrome.Paradigm shift in surgical approaches to thymectomy.Therapeutic apheresis in neurology critical care.Characteristics and mechanism of neuromuscular block in myasthenia gravis.Alzheimer's disease drugs: an application of the hormetic dose-response model.Autoantibodies in neuromuscular autoimmune disorders.Thymus pathology observed in the MGTX trial.Strategies for the treatment of myasthenia gravis.The course of myasthenia gravis and therapies affecting outcome.Mechanisms of neuromuscular block. A review article.Myasthenia gravis--validation of a hypothesis.ACTH and neuromuscular transmission: electrophysiological in vitro investigation of the effects of corticotropin and an ACTH fragment on neuromuscular transmission.Strategies for treatment of myasthenia gravis.Something in the Blood? A history of the autoimmune hypothesis regarding myasthenia gravis.Two steps forward, one step back: mycophenolate mofetil treatment for myasthenia gravis in the United States.The natural course of myasthenia gravis and effect of therapeutic measures.The contribution of Dr. Mary Walker towards myasthenia gravis and periodic paralysis whilst working in poor law hospitals in London.Mary Broadfoot Walker: 83 years since a historical discovery.Physostigmine and neuromuscular transmission.Muscle relaxants in clinical practice.Crisis, precrisis and drug resistance in myasthenia gravis.
P2860
Q24187268-ECF02162-AA95-4AFD-B25D-DA90A8A4B997Q33150809-FE177A17-0E5E-44F2-994D-383C9E790CA4Q33985513-334C0621-F308-4913-A1CE-E89E2C0EBE6FQ34542581-A0F3359F-EF65-4F57-94FC-68FCEEEEEABBQ34572505-8F5911DB-06F1-48BA-B444-8AC9F0BFAD3BQ36215377-17A60738-4D28-49E6-89AC-2163B62D4928Q37116097-ABED285A-BD22-43DB-9909-340DFC483374Q37196488-747DA7E8-2F35-4654-952E-CB130B356C55Q37754738-6CEA50F7-BBBA-440B-98D0-4D198D09101EQ38070759-CB051873-C7D6-4E8F-BBAC-EE3D3F4776E4Q39302720-21E5E5AF-864E-4E31-A6AF-E2B2F412A747Q39683344-91FEE3A9-A8E8-4D93-B089-CB9C87C87426Q39981242-6BC616E2-CFB2-4EDB-8189-E02E69C11986Q40086969-CD83B139-158D-4C4A-94A1-E2A88021FD2FQ40088394-A6D83C64-EAD5-409C-AD2A-9C563B23867FQ40838126-C4D7BE5C-528F-4F01-8807-B0AA57060B9CQ43536092-D4D12079-ABE3-4B98-9235-66100EBD5D3DQ44092529-A3F6DB37-9AA0-44B6-A401-34F41EE6775DQ44355391-390F097D-6DD4-43DD-BBD0-517F59A4C092Q46600795-F067AFA5-6706-4205-A19F-D5BE0A60E5B7Q47547896-F9ACD7A2-52B4-45BE-85FA-C4BCE8A01951Q48265840-D54CC976-3E8D-45C7-AA95-2A8E13099F37Q52787107-76BDB4E1-1476-46D2-AB79-2224B2C7AE06Q54708129-3E78289A-508E-4659-A368-5C94F0F9B0DB
P2860
description
article publié dans la revue scientifique The Lancet
@fr
im Juni 1934 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published in The Lancet
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в червні 1934
@uk
ശാസ്ത്രപ്രബന്ധം
@ml
name
TREATMENT OF MYASTHENIA GRAVIS WITH PHYSOSTIGMINE
@en
TREATMENT OF MYASTHENIA GRAVIS WITH PHYSOSTIGMINE
@nl
type
label
TREATMENT OF MYASTHENIA GRAVIS WITH PHYSOSTIGMINE
@en
TREATMENT OF MYASTHENIA GRAVIS WITH PHYSOSTIGMINE
@nl
prefLabel
TREATMENT OF MYASTHENIA GRAVIS WITH PHYSOSTIGMINE
@en
TREATMENT OF MYASTHENIA GRAVIS WITH PHYSOSTIGMINE
@nl
P1433
P1476
TREATMENT OF MYASTHENIA GRAVIS WITH PHYSOSTIGMINE
@en
P2093
M.B. Walker
P304
P356
10.1016/S0140-6736(00)94294-6
P407
P577
1934-06-01T00:00:00Z